Zentalis Pharmaceuticals, Inc. (ZNTL) Q4 2024 Annual Earnings
ZNTL·Reported March 26, 2025·Before market open
Zentalis Pharmaceuticals, Inc. reported Q4 2024 revenue of $26.9M. Diluted EPS came in at $-0.66, beat the $-0.75 consensus by $0.09.
Revenue
$26.9M
Diluted EPS
$-0.66beat by $0.09
Consensus: $-0.75
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Zentalis Pharmaceuticals, Inc.'s Q4 2024 earnings report.
Zentalis Pharmaceuticals, Inc. (ZNTL) reported Q4 2024 earnings on March 26, 2025 before market open.
Zentalis Pharmaceuticals, Inc. reported revenue of $26.9M and diluted EPS of $-0.66 for Q4 2024.
EPS beat the consensus estimate of $-0.75 by $0.09.
You can read the 10-K periodic report (0001725160-25-000067) directly on SEC EDGAR. The filing index links above go to sec.gov.